Rapid optical imaging of human breast tumour xenografts using anti-HER2 VHHs site-directly conjugated to IRDye 800CW for image-guided surgery

Clinically Used Breast Cancer Markers Such As Estrogen Receptor, Progesterone Receptor, and Human Epidermal Growth Factor Receptor 2 Are Unstable Throughout Tumor Progression

(2012) Linda Sofie Lindström et al.   JOURNAL OF CLINICAL ONCOLOGY

Preclinical evaluation of 227Th-labeled and 177Lu-labeled trastuzumab in mice with HER-2-positive ovarian cancer xenografts

(2012) Nasir Abbas et al.   NUCLEAR MEDICINE COMMUNICATIONS

A novel method to quantify IRDye800CW fluorescent antibody probes ex vivo in tissue distribution studies

(2012) Sabrina Oliveira et al.   EJNMMI Research

Translation of Near-Infrared Fluorescence Imaging Technologies: Emerging Clinical Applications

(2011) E.M. Sevick-Muraca   Annual Review of Medicine

Current technologies for HER2 testing in breast cancer

(2011) C.B. Moelans et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

Preclinical screening of anti-HER2 nanobodies for molecular imaging of breast cancer

(2011) Ilse Vaneycken et al.   FASEB JOURNAL

Drug targeting to tumors: Principles, pitfalls and (pre-) clinical progress

(2011) Twan Lammers et al.   JOURNAL OF CONTROLLED RELEASE

Intraoperative Near-Infrared Fluorescence Tumor Imaging with Vascular Endothelial Growth Factor and Human Epidermal Growth Factor Receptor 2 Targeting Antibodies

(2011) A. G. T. Terwisscha van Scheltinga et al.   JOURNAL OF NUCLEAR MEDICINE

Intraoperative tumor-specific fluorescence imaging in ovarian cancer by folate receptor-α targeting: first in-human results

(2011) Gooitzen M van Dam et al.   NATURE MEDICINE

Localization, mechanism and reduction of renal retention of technetium-99m labeled epidermal growth factor receptor-specific nanobody in mice

(2010) Lea Olive Tchouate Gainkam et al.   Contrast Media & Molecular Imaging

Molecular imaging of HER2-positive breast cancer: a step toward an individualized ‘image and treat’ strategy

(2010) Jacek Capala et al.   CURRENT OPINION IN ONCOLOGY

Intratumoral heterogeneity of HER-2 gene amplification and protein overexpression in breast cancer

(2010) Julie M. Wu et al.   HUMAN PATHOLOGY

Molecular Imaging of HER2-Expressing Malignant Tumors in Breast Cancer Patients Using Synthetic 111In- or 68Ga-Labeled Affibody Molecules

(2010) R. P. Baum et al.   JOURNAL OF NUCLEAR MEDICINE

The HER2 testing conundrum

(2010) Malorye Allison   NATURE BIOTECHNOLOGY

A modeling analysis of the effects of molecular size and binding affinity on tumor targeting

(2009) M. M. Schmidt et al.   MOLECULAR CANCER THERAPEUTICS

Affibody Molecules for In vivo Characterization of HER2-Positive Tumors by Near-Infrared Imaging

(2008) S. B. Lee et al.   CLINICAL CANCER RESEARCH

Prognostic Factors in Metastatic Breast Cancer: Successes and Challenges Toward Individualized Therapy

(2008) Eleni Andreopoulou et al.   JOURNAL OF CLINICAL ONCOLOGY

SPECT Imaging with 99mTc-Labeled EGFR-Specific Nanobody for In Vivo Monitoring of EGFR Expression

(2008) Lieven Huang et al.   MOLECULAR IMAGING AND BIOLOGY